Tsuchiya, Miyako http://orcid.org/0000-0003-4670-1702
Masujima, Mariko
Kato, Tomoyasu
Ikeda, Shun-ichi
Shimizu, Chikako
Kinoshita, Takayuki
Shiino, Sho
Suzuki, Makiko
Mori, Miki
Takahashi, Miyako
Funding for this research was provided by:
the Foundation for Promotion of Cancer Research (None)
the National Cancer Center Research and Development Fund (28-A-23)
Article History
Received: 28 February 2018
Accepted: 9 July 2018
First Online: 16 July 2018
Compliance with ethical standards
:
: Chikako Shimizu reports personal consultancy fee from Eizai and Pfizer, and grants from Pfizer, Chugai, MSD and Eli Lilly, outside the submitted work. Miyako Tsuchiya, Mariko Masujima, Tomoyasu Kato, Shun-ichi Ikeda, Takayuki Kinoshita, Sho Shiino, Makiko Suzuki, Miki Mori, and Miyako Takahashi have nothing to declare.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. For this type of study, formal consent is not required.
: Informed consent was obtained from all individual participants included in the study.